Precision BioSciences Inc (DTIL) — Financial Flexibility Index
Precision BioSciences Inc (DTIL) has a Financial Flexibility Index of -0.17x as of June 2026. Free cash flow of $-13.42 Million (operating CF $-13.44 Million minus capex $18.00K) represents 0% of total liabilities ($80.63 Million). Check Precision BioSciences Inc (DTIL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Precision BioSciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Precision BioSciences Inc across 10 annual periods. For the full cash flow conversion analysis, see DTIL cash generation efficiency.
Annual Financial Flexibility Index for Precision BioSciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Precision BioSciences Inc. Explore how well can Precision BioSciences Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.06x | $-65.76 Million | $-65.84 Million | $62.17 Million | ▼ -45.4% |
| 2024 | -0.73x | $-58.20 Million | $-58.45 Million | $80.00 Million | ▼ -25.3% |
| 2023 | -0.58x | $-81.84 Million | $-84.11 Million | $140.92 Million | ▼ -143.2% |
| 2022 | -0.24x | $-42.43 Million | $-45.75 Million | $177.74 Million | ▼ -468.9% |
| 2021 | -0.04x | $-5.05 Million | $-10.85 Million | $120.33 Million | ▲ +94.6% |
| 2020 | -0.78x | $-82.36 Million | $-87.39 Million | $105.73 Million | ▼ -54.2% |
| 2019 | -0.51x | $-48.97 Million | $-73.64 Million | $96.92 Million | ▼ -38.3% |
| 2018 | -0.37x | $-36.05 Million | $-51.72 Million | $98.64 Million | ▼ -94.6% |
| 2017 | -0.19x | $-18.60 Million | $-24.17 Million | $99.05 Million | ▼ -120.5% |
| 2016 | 0.91x | $94.35 Million | $92.27 Million | $103.16 Million | — |